Why the study?
Does the R1232W/T1620M double SCN5A mutation cause a trafficking defect leading to a non-functioning Na channel?
Does the R1232W/T1620M double SCN5A mutation cause a trafficking defect leading to a non-functioning Na channel?
Contrary to previous reports, the R1232W/T1620M double SCN5A mutation does not cause a trafficking defect or loss of Na channel function.
Challenges prior trafficking-defect reports for R1232W/T1620M; leaves open its clinical relevance and alternative mechanisms in SCN5A carriers.
BACKGROUND: A trafficking defect of mutant cardiac Na-channels (SCN5A) has been implicated in Brugada syndrome. Although R1232W polymorphism and T1620M mutation by themselves have little effect on Na-channel function, their combination has been reported to disrupt membrane trafficking, resulting in a non-functioning Na channel. METHODS AND RESULTS: Contrary to previous findings, patch-clamp recordings of heterologously expressed R1232W/T1620M showed robust Na currents and confocal microscopy exhibited predominant expression in the plasma membrane, similar to the wild-type channel. CONCLUSIONS: It is unlikely that an intragenic interaction between R1232W and T1620M of SCN5A causes a trafficking defect leading to a non-functioning Na channel.
No takes yet. Share an insight, caveat, or question.
Makita et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: